Scientists on Long Island are preparing to move a 50-foot-wide electromagnet 3,200 miles over land and sea to its new home at the U.S. Department of Energy's Fermi National Accelerator Laboratory in Illinois. The trip, starting at Brookhaven National Laboratory, is expected to take more than a month.
Agilent Technologies Inc. this week announced that the Broad Institute in Cambridge,...
Scientists on Long Island are preparing to move a 50-foot-wide electromagnet 3,200...
Boeing Corp. is starting work on a stretched-out version of its popular 787 Dreamliner jet, in the hope of reigniting interest in the aircraft after battery-related problems. Boeing announced the formal launch of its 787-10 program at the Paris Air Show on Tuesday and says it already has commitments from several customers, including United Airlines.
Oven Industries has announced the new 5R1-1400 AC Temperature Controller with the integrated potentiometers or via a PC through the TTL level UART communication port. This compact design measuring two and one half inches square can deliver up to 15 AMPS of load current from a zero voltage switched, low noise solid state relay.
Gel permeation/size exclusion chromatography (GPC/SEC) is a central analytical technique for the analysis of proteins, polymers, and macromolecules. When integrated into GPC/SEC set ups, the Viscotek viscometer detector from Malvern Instruments can help deliver the enhanced information needed to achieve challenging performance specifications.
JPK Instruments reports on the Yan Jie single-molecule biophysics research group at the Mechanobiology Institute (MBI) of the National Univ. of Singapore (NUS) and their use of optical tweezers. The MBI of the NUS was created through joint funding by the National Research Foundation and the Ministry of Education with the goal of creating a new research center in mechanobiology to benefit both the discipline and Singapore.
In this video, Tim Samaras from the National Geographic Channel Storm Chasers talks about his passion for chasing and studying storm systems. He explains how he used National Instruments’ (NI) LabVIEW and CompactDAQ in a new instrument that is deployed on the ground in front of a tornado. After the storm he uses another NI application, DIAdem, to view the data that was collected.
New research raises fresh questions about which cancer patients benefit from Avastin, a drug that lost its approval for treating breast cancer nearly two years ago. Two studies found that Avastin did not prolong life when used as a first treatment for people with brain tumors like the one U.S. Sen. Edward Kennedy died of several years ago. Side effects also were more common with Avastin.
A federal judge has approved a settlement in which United Technologies Corp. will sell some of its assets as part of its $18.4 billion purchase of aerospace-parts maker Goodrich Corp., the largest merger in aircraft industry history. The settlement between Hartford, Connecticut-based United Technologies and the Justice Department was approved Wednesday by U.S. District Court Judge Ketanji Brown Jackson.
British drugmaker GlaxoSmithKline PLC said Wednesday that it will buy Okairos AG for about $323 million, gaining the Swiss vaccine developer's products. GlaxoSmithKline said Okairos is studying vaccine technology that could be used in shots that can both prevent and cure infections or diseases.
Leaders of the National Science Foundation (NSF) and the Semiconductor Research Corporation (SRC), the world's leading university-research consortium for semiconductors and related technologies, this week announced 18 new projects funded through a joint initiative to address research challenges in the design of failure-resistant circuits and systems.
An unmanned jet built for U.S. Navy high-altitude maritime surveillance missions has made its first flight. Northrop Grumman Corp. says the MQ-4C Triton took off from Palmdale, Calif., Wednesday and completed a 90-minute flight. The aircraft is designed to fly missions lasting up to 24 hours at altitudes greater than 10 miles, allowing coverage out 2,000 nautical miles.
The Nevada Senate has endorsed NV Energy Inc.'s plan to retire its coal-fired plants and pave the way for the state's biggest electrical utility to transition to more renewable sources. After several revisions, SB123 was approved unanimously Wednesday and now moves to the Assembly.
Specialty drugmaker Biogen Idec said Tuesday it submitted a new injectable multiple sclerosis drug to the Food and Drug Administration for U.S. market approval. The drug, called Plegridy, is intended to treat patients with relapsing forms of multiple sclerosis.
The solar industry in Georgia is pushing a power monopoly to expand its use of solar energy as it plans to meet the state's electricity needs over the next two decades. State utility regulators heard testimony Tuesday on the energy plans from Southern Co. subsidiary Georgia Power, which must submit new plans every three years.
Columbia University has signed a licensing agreement with Varian Medical Systems for new imaging software that facilitates 3D segmentation, the process by which anatomical structures in medical images are distinguished from one another—an important step in the precise planning of cancer surgery and radiation treatments.
Shares of XenoPort Inc. sank Monday after the drug developer said a potential treatment for multiple sclerosis patients failed in late-stage clinical testing, and it will stop developing the drug. The Santa Clara, Calif., company said the treatment, labeled arbaclofen placarbil, failed to show a statistically significant improvement for patients taking it compared to a fake drug.
A Colorado company developing a spaceship to take astronauts to the International Space Station is having elements of its spacecraft undergo landing-related tests at NASA facilities in Virginia and California. NASA wants private firms to ferry astronauts into low-Earth orbit so it can focus on deep-space exploration and send crews to a nearby asteroid and eventually Mars.
State pharmacy officials on Thursday threw their support behind a proposal giving the Food and Drug Administration authority over large compounding pharmacies, in an effort to head off more outbreaks tied to contaminated medications. The head of the National Association of Boards of Pharmacy told Senate lawmakers that his group welcomes FDA action against pharmacies.
Anyone who has seen pictures of the giant, red-hot cauldrons in which steel is made—fed by vast amounts of carbon, and belching flame and smoke—would not be surprised to learn that steelmaking is one of the world’s leading industrial sources of greenhouse gases. But remarkably, a new process developed by Massachusetts Institute of Technology researchers could change all that.
DATAQ Instruments has released its new DI-145 USB data acquisition instrument, the latest in a long line of low-cost starter kits. A fraction of the cost of similarly equipped products, the DI-145 includes four ±10 V analog channels and two dedicated digital inputs.
Ocean Optics has released the IDRaman mini handheld Raman spectrometer, a small, powerful instrument with exceptional performance for sample authentication and counterfeit detection, identification, and verification.
Swedish and Spanish engineers have created a system of sensors that detects fruit odors more effectively than the human sense of smell. For now, the device, which has 32 sensors and can process scent data in real time, can distinguish between the odorous compounds emitted by pears and apples, but the system can be tailored to other applications.
Dow Chemical Co. said Tuesday it received a $2.2 billion payment from Petrochemical Industries Company of Kuwait, settling a dispute over a scrapped joint venture. A year ago, an international arbitration court awarded Dow $2.2 billion in damages stemming from Kuwait's move to withdraw from the joint venture.
Medtronic has put two new implantable heart devices on the market after receiving approval from federal regulators. The FDrA approved the sale of the Viva heart resynchronization devices and Evera implantable cardioverter defibrillators. Cardiac resynchronization therapy devices are used to treat heart failure and implantable defibrillators are used to treat rapid heartbeats.
Bristol-Myers Squibb Co. said Friday that U.S. regulators expanded approval of its HIV drug Sustiva to children as young as three months old. The capsule-based drug was first approved in 1998 to treat HIV-infected children who are age three and older and weigh at least 22 pounds. The new approval expands the drug's use to children age three months to three years who weigh at least 7.7 pounds.
As markets for miniature, hybrid machines known as MEMS grow and diversify, NIST has introduced a long-awaited measurement tool that will help growing numbers of device designers, manufacturers and customers to see eye to eye on eight dimensional and material property measurements that are key to device performance.